AFRITEL

This brand name is authorized in Nigeria.

Active ingredients

The drug AFRITEL contains one active pharmaceutical ingredient (API):

1
UNII U5SYW473RQ - TELMISARTAN
 

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.

 
Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-6538 Tablet AFRITEL 40 TABLET TAB 40 mg AFRITEL 40 TABLET B4-6538 AFRITEL 40 TABLET Active ingredients: Telmisartan 40mg USP Excipients: Sodium Hydrochloride BP Meglumine BP, Mannitol BP, Povidone K-30BP, Purified Water BP, Magnesium Stearate BP Prescription Only Medicine (POM) CHANRAI HEALTHCARE LIMITED, OSHODI APAPA EXPRESSWAY, ISOLO LAGOS BHARAT PARENTERALS LTD, , SURVEY NO: 144&146, JAROD SAMLAYA RD, VILL. HARIPURA, TA. SAVLI DIST VADODARA - 391520, GUJARAT, INDIA, India 2/23/2023 2/22/2028 23/02/2023
B4-6539 Tablet AFRITEL 40H TABLET TAB 40 mg; 12.5 mg AFRITEL 40H TABLET B4-6539 AFRITEL 40H TABLET Active: Telmisartan USP 40mg, Hydrochlorothiazide 12.5mg Excipients: Sodium Hydroxide BP, Meglumine BP, Mannjtol BP, Povidone K-30 BP, Purified Water BP, Magnesium Stearate BP, Pregelatinized Starch BP, Colloidal Anhydrous Silica POM 1 CHANRAI HEALTHCARE LIMITED, OSHODI APAPA EXPRESSWAY, ISOLO LAGOS BHARAT PARENTERALS LTD, , SURVEY NO: 144&146, JAROD SAMLAYA RD, VILL. HARIPURA, TA. SAVLI DIST VADODARA - 391520, GUJARAT, INDIA, India 2/23/2023 2/22/2028 23/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09CA07 Telmisartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-6538, B4-6539

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.